Target intelligence / Profile preview

Histidine triad nucleotide binding protein 2 pseudogene 1 (HINT2P1)

Target
HINT2P1
Molecular classification
Other (Pseudogene)
01

Overview

Histidine triad nucleotide binding protein 2 pseudogene 1 (HINT2P1) is a **pseudogene**, meaning it is a DNA sequence homologous to a functional gene (in this case, HINT2), but is generally considered nonfunctional as it does not encode a protein product[1][3][4]. Pseudogenes can arise by duplication, retrotransposition, or mutation of coding genes and are typically transcriptionally inactive, although some are transcribed into noncoding RNAs[2][4]. Pseudogenes, including HINT2P1, are not classified as valid therapeutic targets because they do not produce proteins and have no documented drug interactions or direct disease relevance[1][2][3][4]. In rare cases, pseudogenes can regulate their parent or related genes via RNA interference mechanisms or as competing endogenous RNAs, but no specific such regulatory function is documented for HINT2P1.

Other names
HINT2 pseudogene 1Histidine triad nucleotide-binding protein 2 pseudogene 1
02

Mechanism of action

None (not a protein-coding gene, not a druggable target)

03

Biological functions

Other (pseudogene; non-protein coding)May have potential non-coding regulatory RNA functions as described for some pseudogenes, including acting as microRNA decoys or generating regulatory RNAs
04

Disease associations

Other (No direct evidence for this specific pseudogene; generally, some pseudogenes can play a role in cancer and other diseases through regulatory mechanisms. No disease association is established for HINT2P1.)
05

Safety considerations

None (not a protein-coding gene, not a therapeutic target)
06

Interacting drugs

None (no known drugs)
07

Biomarkers

None (not established as a biomarker)

Beyond the preview

Go deeper on Histidine triad nucleotide binding protein 2 pseudogene 1 (HINT2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histidine triad nucleotide binding protein 2 pseudogene 1 (HINT2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call